Melatonin: A frustrated hope in the acute phase of the COVID-19 pandemic, a therapeutic possibility in prolonged COVID
Melatonin is particularly effective in reducing symptomatology of SARS-CoV-2 infection due to its roles as an antioxidant, anti-inflammatory, and immunomodulatory agent. Melatonin is also an effective chronobiotic/hypnotic medication for treating delirium and restoring circadian imbalance in COVID p...
Guardado en:
| Autor principal: | Cardinali, Daniel P. |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Asociación de Medicina del Estrés y Psicoinmunoneuroendocrinología
2023
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/pinelatam/article/view/39717 |
| Aporte de: |
Ejemplares similares
-
Commentary on the article published by Russel Reiter and Daniel Cardinali and their collaborators: Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
por: Pasqualini, María Eugenia
Publicado: (2022) -
High doses of melatonin as a potential therapeutic tool for the neurologic sequels of covid-19 infection
por: Cardinali, Daniel Pedro
Publicado: (2022) -
Melatonin as an add-on treatment of COVID-19 infection : current status
por: Brown, Gregory M., et al.
Publicado: (2022) -
Can melatonin be a potential “silver bullet” in treating covid-19 patients?
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022) -
A preliminar study of a neuroimmune regimen with lowdose angiotensin 1-7 plus melatonin to improve the safety of covid 19 vaccine
por: Lissoni, Paolo, et al.
Publicado: (2022)